News

CRESTWOOD, KY, 21st October 2019 – Liberate Medical, a medical device company developing novel non-invasive electrical muscle stimulation devices to help patients with pulmonary conditions, today announced that it has received CE marking for its VentFree™ Respiratory Muscle Stimulator and ISO 13485 certification for its quality management system. The VentFree stimulator applies proprietary non-invasive electrical […]

Houston, TX (August 6, 2019) – Procyrion, Inc., a clinical-stage medical device company developing the Aortix™ system, a percutaneous blood pump initially targeted for treating patients with heart failure and worsening kidney function (cardiorenal syndrome), announced the appointment of Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing. In this role, Edidin will

Houston, TX (July 30, 2019) – Procyrion, Inc., a medical device company developing percutaneous circulatory support devices for the treatment of heart failure, announced today that it has secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Aortix™ System. Aortix is a circulatory support device for chronic heart failure patients

Houston, TX (July 9, 2019) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $30 million Series D funding round led by a new investor, Bluebird Ventures. Returning investors include Fannin Partners, Scientific Health Development, the State of Texas, and an undisclosed strategic investor. The company is developing its Aortix™ system,

Care management company prepares to further growth in the private health plan market SOMERVILLE, Mass., July 9, 2019 — Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcers, today announced Simon Salgado has joined the team as Vice President, Enterprise Health Services. Salgado spent the last

Results Presented as an Oral Presentation Crestwood, KY, May 21, 2019 – Liberate Medical, a clinical-stage medical device company, developing novel electrical muscle stimulation devices that non-invasively address pulmonary conditions, today announced the results from its recently completed pilot trial of the VentFree Muscle Stimulator during an oral presentation at the American Thoracic Society International Conference (“ATS”)

Investment will accelerate the company’s business development among VA hospitals and commercial payers SOMERVILLE, Mass., May 9, 2019 — Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcers (DFUs), today announced it has closed a $13.4 million Series B funding round. Participants included Rock Health, Norwich

Emeryville, California, April 2, 2019. Channel Medsystems®, a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that the U.S. Food and Drug Administration (FDA) has approved the Cerene® Cryotherapy Device as a new approach to treating heavy menstrual bleeding. The Cerene Device delivers cryotherapy to freeze the lining of the

Crestwood, KY, 24th January 2019 – Liberate Medical, a clinical stage medical device company, focused on the development of novel non-invasive neuromuscular electrical stimulation devices to address pulmonary conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s VentFree muscle stimulator. The proposed indication for the

HOUSTON, TEXAS (August 23, 2018) – Houston medical device developer Procyrion Inc. today announced they have won the Most Innovative Heart Pump Technology award in the 2018 Global Healthcare and Pharmaceutical Awards for their device, Aortix™, a catheter-deployed circulatory support device designed initially to address cardiorenal syndrome in heart failure patients. The award celebrates the